Soluble amyloid-β dimers are resistant to amyloid-β prion conversion in vivo suggesting antiprion properties.

van Gerresheim EF, Müller-Schiffmann A, Schäble S, Koopmans B, Loos M, Korth C

Open source

DOI
10.1111/nan.12895
Published
2023 Apr
Container
Neuropathology and applied neurobiology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/nan.12895,
  title = {Soluble amyloid-β dimers are resistant to amyloid-β prion conversion in vivo suggesting antiprion properties.},
  author = {van Gerresheim EF and Müller-Schiffmann A and Schäble S and Koopmans B and Loos M and Korth C},
  year = {2023},
  journal = {Neuropathology and applied neurobiology},
  doi = {10.1111/nan.12895},
  url = {https://doi.org/10.1111/nan.12895}
}

RIS

TY  - JOUR
TI  - Soluble amyloid-β dimers are resistant to amyloid-β prion conversion in vivo suggesting antiprion properties.
AU  - van Gerresheim EF
AU  - Müller-Schiffmann A
AU  - Schäble S
AU  - Koopmans B
AU  - Loos M
AU  - Korth C
PY  - 2023
JO  - Neuropathology and applied neurobiology
DO  - 10.1111/nan.12895
UR  - https://doi.org/10.1111/nan.12895
ER  - 

APA

EF, V. G., A, M., S, S., B, K., M, L., & C, K. (2023). Soluble amyloid-β dimers are resistant to amyloid-β prion conversion in vivo suggesting antiprion properties.. Neuropathology and applied neurobiology. https://doi.org/10.1111/nan.12895

Source records